This effect is mediated by the enhancement of cyclooxygenase-2 (COX-2) expression, and by the production of PGE (2) and 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)), key factors involved in the resolution of brain inflammation [96]. Here, PTGS2 is linked to brain inflammatory disease.